Science supporting the art of medicine: improving the management of breathlessness

Parshall MB Schwartzstein RM Adams L . An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185(4): 435–452.

Gracely RH Undem BJ Banzett RB . Cough, pain and dyspnoea: similarities and differences. Pulm Pharmacol Ther 2007; 20(4): 433–437.

Murtagh FEM Addington-Hall JM Donohoe P . Symptom management in patients with established renal failure managed without dialysis. J Renal Care 2006; 32: 93–98.

Walker JM Farney RJ Rhondeau SM . Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007; 3(5): 455–461.

The British Pain Society. Opioids for persistent pain: good practice. London: The British Pain Society, 2010.

Booth S Farquhar M Gysels M . The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnoea: a qualitative phase 1 study. Palliat Support Care 2006; 4: 287–293.

Spathis A . Assessment of breathlessness. In: Booth S Moffat CM Burkin J . (eds) Breathlessness management in clinical practice. Springer-Verlag, in press.